Daiwa Securities Group Inc. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 18 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$637,000
+48.8%
886,000
+39.3%
0.01%
+25.0%
Q3 2019$428,000
-3.2%
636,0000.0%0.00%0.0%
Q2 2019$442,000636,0000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 37,825,000$25,876,0003.78%
PenderFund Capital Management Ltd. 13,060,000$9,300,0003.13%
Telemetry Investments, L.L.C. 1,500,000$1,084,0003.13%
Context Capital Management, LLC 1,600,000$1,157,0000.66%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 27,750,000$20,019,000,0000.56%
PALISADE CAPITAL MANAGEMENT, LP 3,750,000$2,712,0000.08%
CAPSTONE INVESTMENT ADVISORS, LLC 7,182,000$5,264,0000.04%
AQR Arbitrage LLC 3,050,000$2,236,0000.03%
Teton Advisors, Inc. 400,000$280,0000.03%
GABELLI FUNDS LLC 3,750,000$2,629,0000.02%
View complete list of PARATEK PHARMACEUTICALS INC shareholders